Onyx Biotec
add_icon

Onyx Biotec

33.00
-1.00
(-2.94%)
Market Cap
59.84 Cr
PE Ratio
12.45
Volume
4,000.00
Day High - Low
34.00 - 33.00
52W High-Low
58.95 - 28.10
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
59.84 Cr
EPS
3.31
PE Ratio
12.45
PB Ratio
1.11
Book Value
30.68
EBITDA
11.50
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
8.91
Debt to Equity
0.53
Forecast For
Actual

Company News

View All News
Caret
neutral
Onyx Biotec: Weak Market Debut with 11.5% Discount on ListingNov 22, 2024
Onyx Biotec listed at ₹54 on NSE SME, 11.5% below its IPO price of ₹61. The stock recovered slightly post-listing to ₹56.75. The ₹29.34 crore IPO was oversubscribed 198 times. Proceeds will be used for manufacturing upgrades, loan repayment, and corporate purposes.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,693.60
#1 4,06,351.37
37.86
#1 54,729.00
9.71
#1 10,980
16.07
37.98
5,856.50
1,55,471.67
63.26
9,712.00
18.67
2,191
-1.02
33.24
3,987.20
1,34,944.97
61.20
11,539.40
6.99
1,911
26.24
32.75
2,274.50
1,03,954.48
22.26
22,909.50
13.74
3,306
#1 37.44
47.35
1,217.30
1,01,601.09
18.27
33,741.20
16.73
5,725
-15.28
39.36
1,192.40
96,319.77
21.31
28,409.50
7.12
5,291
-57.18
26.86
864.25
86,963.77
#1 17.29
23,511.00
18.55
4,615
-0.32
41.42
1,998.50
82,499.09
45.81
12,744.20
#1 20.90
2,007
7.65
41.40
1,333.70
77,461.51
22.37
32,345.60
9.43
3,484
7.59
64.38
5,258.00
62,867.28
25.87
13,458.30
3.70
2,216
1.90
42.54
Growth Rate
Revenue Growth
17.07 %
Net Income Growth
38.89 %
Cash Flow Change
-6.58 %
ROE
-38.00 %
ROCE
1.02 %
EBITDA Margin (Avg.)
16.10 %

Yearly Financial Results

Annual Financials
2022
2023
2024
2025
TTM
Revenue
45
40
54
63
0
Expenses
39
35
45
52
0
EBITDA
6
5
9
12
0
Operating Profit %
13 %
11 %
16 %
17 %
0 %
Depreciation
1
2
2
3
0
Interest
1
1
2
2
0
Profit Before Tax
4
3
5
7
0
Tax
0
1
1
2
0
Net Profit
3
2
4
5
0
EPS in ₹
2.84
1.56
3.05
3.31
0.00

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
37
59
74
91
Fixed Assets
17
43
44
41
Current Assets
14
15
30
49
Capital Work in Progress
4
0
0
0
Investments
0
0
0
0
Other Assets
16
16
31
50
Total Equity & Liabilities
37
59
74
91
Current Liabilities
10
20
23
26
Non Current Liabilities
10
20
26
10
Total Equity
16
18
25
56
Reserve & Surplus
11
12
12
38
Share Capital
6
6
13
18

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
-0
-4
2
7
Investing Activities
-6
-23
-3
1
Operating Activities
1
2
2
1
Financing Activities
5
16
3
5

Share Holding

% Holding
Nov 2024
Mar 2025
Sept 2025
Promoter
65.10 %
65.10 %
65.10 %
FIIs
0.00 %
0.00 %
0.00 %
DIIs
0.03 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
18.96 %
18.97 %
22.64 %
Others
15.92 %
15.94 %
12.27 %
No of Share Holders
1,181
551
640

Technical Indicators

RSI(14)
Neutral
49.01
ATR(14)
Less Volatile
2.08
STOCH(9,6)
Neutral
50.10
STOCH RSI(14)
Overbought
90.15
MACD(12,26)
Bullish
0.26
ADX(14)
Weak Trend
12.36
UO(9)
Bearish
58.18
ROC(12)
Uptrend And Accelerating
0.61
WillR(14)
Neutral
-54.55